You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 109 No. 5, May 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Renal Excretion of Uric Acid in Leukemia and Gout

C. A. NUGENT, M.D.; W. D. MacDIARMID, M.D.; FRANK H. TYLER, M.D.

Arch Intern Med. 1962;109(5):540-544.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The basis for the frequent occurrence of an elevation of the plasma urate concentration in patients with gout has interested investigators for many years. Increased urate production, decreased nonrenal urate disposal, and decreased urinary urate excretion all have been considered as possible causes of hyperuricemia in patients with gout.1-6 In an attempt to clarify this problem, we have examined the role of the kidneys in regulating plasma urate concentration by studying patients who are likely to have increased endogenous urate production due to diseases unrelated to primary gout. Adult male patients with leukemia were studied. Their plasma uric acid concentrations, 24-hour urinary urate excretion, and urate-to-creatinine excretion ratios were compared with the results of similar studies performed on normal subjects and on patients with gout.

Methods

Twelve male patients with acute lymphoblastic, acute myeloblastic, or chronic myelocytic leukemia were studied. Patients with chronic lymphocytic leukemia were excluded from the . . . [Full Text PDF of this Article]


Author Affiliations

SALT LAKE CITY

From the Department of Medicine and the Laboratory for the Study of Hereditary and Metabolic Disorders, University of Utah College of Medicine.


Footnotes

Submitted for publication June 17, 1961.

This work was supported in part by Grants A-2 and A-1829 from the National Institute of Arthritis and Metabolic Diseases, National Institutes of Health.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.